{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:49:11Z","timestamp":1788587351341,"version":"build-2803163510"},"reference-count":40,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej18-0486","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T17:03:28Z","timestamp":1573059808000},"page":"141-152","source":"Crossref","is-referenced-by-count":90,"title":["A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features"],"prefix":"10.1507","volume":"67","author":[{"given":"Takamasa","family":"Ichijo","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Saiseikai Yokohamashi Tobu Hospital, Yokohama 230-0012, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Ueshiba","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Toho University School of Medicine, Tokyo 143-8541, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Nawata","sequence":"additional","affiliation":[{"name":"Honorary President, Muta Hospital, Fukuoka 814-0163, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Yanase","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Brunt LM, Moley JF (2001) Adrenal incidentaloma. World J Surg 25: 905\u2013913.","DOI":"10.1007\/s00268-001-0029-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Mantero F, Arnaldi G (2000) Management approaches to adrenal incidentalomas. A view from Ancona, Italy. Endocrinol Metab Clin North Am 29: 107\u2013125, ix.","DOI":"10.1016\/S0889-8529(05)70119-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, et al. (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175: G1\u2013G34.","DOI":"10.1530\/EJE-16-0467"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Young WF Jr (2007) Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356: 601\u2013610.","DOI":"10.1056\/NEJMcp065470"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Jenkins PJ, Chew SL, Lowe DG, Reznek RH, Wass JA (1994) Adrenocorticotrophin-independent unilateral macronodular adrenal hyperplasia occurring with myelolipoma: an unusual cause of Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 41: 827\u2013830.","DOI":"10.1111\/j.1365-2265.1994.tb02800.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T (2001) The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf) 54: 797\u2013804.","DOI":"10.1046\/j.1365-2265.2001.01274.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169: 5\u201311.","DOI":"10.1016\/S0022-5347(05)64023-2"},{"key":"8","unstructured":"8 Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocr Rev 16: 460\u2013484."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Miller BS, Else T, AACE Adrenal Scientific Committee (2017) Personalized care of patients with adrenocortical carcinoma: a comprehensive approach. Endocr Pract 23: 705\u2013715.","DOI":"10.4158\/EP161719.RA"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, et al. (2003) Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d). Ann Intern Med 138: 424\u2013429.","DOI":"10.7326\/0003-4819-138-5-200303040-00013"},{"key":"11","unstructured":"11 Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, et al. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85: 637\u2013644."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, et al. (2009) The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 15 Suppl 1: 1\u201320.","DOI":"10.4158\/EP.15.S1.1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Lee JM, Kim MK, Ko SH, Koh JM, Kim BY, et al. (2017) Clinical Guidelines for the Management of Adrenal Incidentaloma. Endocrinol Metab (Seoul) 32: 200\u2013218.","DOI":"10.3803\/EnM.2017.32.2.200"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, et al. (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25: 309\u2013340.","DOI":"10.1210\/er.2002-0031"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Peppercorn PD, Grossman AB, Reznek RH (1998) Imaging of incidentally discovered adrenal masses. Clin Endocrinol (Oxf) 48: 379\u2013388.","DOI":"10.1046\/j.1365-2265.1998.00475.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 McLoughlin RF, Bilbey JH (1994) Tumors of the adrenal gland: findings on CT and MR imaging. AJR Am J Roentgenol 163: 1413\u20131418.","DOI":"10.2214\/ajr.163.6.7992738"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Odagiri E, Naruse M, Terasaki K, Yamaguchi N, Jibiki K, et al. (2004) The diagnostic standard of preclinical Cushing\u2019s syndrome: evaluation of the dexamethasone suppression test using various cortisol kits. Endocr J 51: 295\u2013302.","DOI":"10.1507\/endocrj.51.295"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Shimizu N, Yoshida H (1976) Studies on the \u201clow dose\u201d suppressible Cushing\u2019s disease. Endocrinol Jpn 23: 479\u2013484.","DOI":"10.1507\/endocrj1954.23.479"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412\u2013419.","DOI":"10.1007\/BF00280883"},{"key":"20","unstructured":"20 Nawata HDH, Suda T, Takayanagi R (1996) Adrenal preclinical Cushing\u2019s syndrome. Annual report of the Ministry of Health and Welfare \u201cDisorder of Adrenal Hormones\u201d Research Committee, Japan 1995: 223\u2013226. (In Japanese)"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Weiss LM, Medeiros LJ, Vickery AL Jr (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13: 202\u2013206.","DOI":"10.1097\/00000478-198903000-00004"},{"key":"22","unstructured":"22 Terzolo M, Osella G, Ali A, Borretta G, Magro GP, et al. (1996) Different patterns of steroid secretion in patients with adrenal incidentaloma. J Clin Endocrinol Metab 81: 740\u2013744."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Barzon L, Sonino N, Fallo F, Palu G, Boscaro M (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149: 273\u2013285.","DOI":"10.1530\/eje.0.1490273"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Bulow B, Ahren B (2002) Adrenal incidentaloma\u2014experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252: 239\u2013246.","DOI":"10.1046\/j.1365-2796.2002.01028.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kim HY, Kim SG, Lee KW, Seo JA, Kim NH, et al. (2005) Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med 20: 303\u2013309.","DOI":"10.3904\/kjim.2005.20.4.303"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Tanabe A, Naruse M, Nishikawa T, Yoshimoto T, Shimizu T, et al. (2001) Autonomy of cortisol secretion in clinically silent adrenal incidentaloma. Horm Metab Res 33: 444\u2013450.","DOI":"10.1055\/s-2001-16234"},{"key":"27","unstructured":"27 Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, et al. (2000) Subclinical Cushing\u2019s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85: 1440\u20131448."},{"key":"28","doi-asserted-by":"publisher","unstructured":"28 Mosso L, Carvajal C, Gonzalez A, Barraza A, Avila F, et al. (2003) Primary aldosteronism and hypertensive disease. Hypertension 42: 161\u2013165.","DOI":"10.1161\/01.HYP.0000079505.25750.11"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29 Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, et al. (2000) The annual report to the nation on the status of cancer, 1973\u20131997, with a special section on colorectal cancer. Cancer 88: 2398\u20132424.","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Reincke M (2000) Subclinical Cushing\u2019s syndrome. Endocrinol Metab Clin North Am 29: 43\u201356.","DOI":"10.1016\/S0889-8529(05)70115-8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Noshiro T, Shimizu K, Watanabe T, Akama H, Shibukawa S, et al. (2000) Changes in clinical features and long-term prognosis in patients with pheochromocytoma. Am J Hypertens 13: 35\u201343.","DOI":"10.1016\/S0895-7061(99)00139-9"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Sawka AM, Prebtani AP, Thabane L, Gafni A, Levine M, et al. (2004) A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endocr Disord 4: 2.","DOI":"10.1186\/1472-6823-4-2"},{"key":"33","unstructured":"33 Lee JA, Zarnegar R, Shen WT, Kebebew E, Clark OH, et al. (2007) Adrenal incidentaloma, borderline elevations of urine or plasma metanephrine levels, and the \u201csubclinical\u201d pheochromocytoma. Arch Surg 142: 870\u2013873; discussion 873\u2013874."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, et al. (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99: 1915\u20131942.","DOI":"10.1210\/jc.2014-1498"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Young WF Jr (1997) Pheochromocytoma and primary aldosteronism: diagnostic approaches. Endocrinol Metab Clin North Am 26: 801\u2013827.","DOI":"10.1016\/S0889-8529(05)70283-8"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, et al. (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101: 1889\u20131916.","DOI":"10.1210\/jc.2015-4061"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, et al. (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322: 1195\u20131201.","DOI":"10.1056\/NEJM199004263221705"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Young WF Jr (2000) Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29: 159\u2013185, x.","DOI":"10.1016\/S0889-8529(05)70122-5"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91: 2027\u20132037.","DOI":"10.1210\/jc.2005-2639"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, et al. (2018) New diagnostic criteria of adrenal subclinical Cushing\u2019s syndrome: opinion from the Japan Endocrine Society. Endocr J 65: 383\u2013393.","DOI":"10.1507\/endocrj.EJ17-0456"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/2\/67_EJ18-0486\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T22:46:58Z","timestamp":1582930018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/2\/67_EJ18-0486\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0486","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}